Search results for “Urotensin-II receptor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 212 patents, we discovered top 15 key players by total patent application. Janssen Pharmaceutica NV, Smithkline Beckman Corp, Sanofi-Aventis SA are dominant in this area. They take 51.42% of the total patent filing.
Janssen Pharmaceutica NV
Antwerpen, Belgium
Patent: 51
Smithkline Beckman Corp
Pennsylvania, United States
Patent: 31
Sanofi-Aventis SA
Spain
Patent: 27
Actelion Pharmaceuticals Ltd.
Basel-Landschaft, Switzerland
Patent: 22
ACADIA Pharmaceuticals, Inc.
California, United States
Patent: 19
Encysive Pharmaceuticals, Inc.
Texas, United States
Patent: 19
Sanofi SA
France
Patent: 17
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 5
Sanofi-Aventis Deutschland GmbH
Hessen, Germany
Patent: 5
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 5
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
No data, please try another search term
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
With the analysis among 22 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Université de Rouen Normandie
France
Patent: 5
Institut National de la Recherche Scientifique
Canada
Patent: 5
Centre Hospitalier Universitaire de Rouen
France
Patent: 3
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: